A second generation assay for antibody to hepatitis C virus (anti-HCV) was used to screen 78 southern Indian individuals with a high risk of infection. RT-PCR targeted at the 5' end untranslated region (5'UTR) of the HCV genome was used to evaluate evidence of viraemia in 32 anti-HCV positive sera. The PCR products amplified from the 5'UTR of the HCV genome from 24 patients were sequenced, revealing the existence of two distinct groups of sequences: 21 corresponded to HCV type 1 while the other three sequences had 95 % to 99 % identity to HCV type 3. Two of these three isolates had more than 90 % nucleotide identity in the NS5 region to established 3b sequences whereas the other had less than 74 % nucleotide identity to any of the published genotype 3 (3a, 3b, 3c, 3d, 3e and 3f) sequences. However, a search of the EMBL nucleotide database revealed 91% identity to the unpublished sequence of an isolate of HCV from Indonesia. We provide evidence that these two isolates may represent a novel subtype within genotype 3. Our data also suggest that HCV genotype 1 predominates over HCV genotype 3 in southern India.
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Hepatitis C virus (HCV), the major cause of parenterally transmitted non-A, non-B hepatitis (Choo et al., 1990) , is distributed worldwide. Infection is most common in those with risk factors of parenteral transmission such as recipients of blood and blood products, including haemophiliacs, renal transplant and dialysis patients, and intravenous drug abusers. Infection also may be transmitted perinatally from mothers with a high titre of circulating virus to their neonates (Ohto et al., 1994) and transmission may also be achieved sexually (Seeff & Alter, 1994) . In many developed countries, the prevalence of infection outside the major risk groups may be as low as 2 to 3 per 1000 (Garson et al., 1992) but the virus seems to be distributed more widely elsewhere, such as in some regions of Japan (Kiyosawa et al., 1994) and Egypt (Kamel et al., 1992) .
HCV is related to flaviviruses and pestiviruses, with a positive sense, ssRNA genome of around 9.4 kb in length (Choo et al., 1990) . The genome comprises an approximately 332 nucleotide 5' end untranslated region * Author for correspondence. Fax +44 I71 794 3472. e-mail tjh@rfhsm.ac.uk
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(5'UTR) followed by a single continuous open reading frame, encoding a polypeptide of around 3010 residues, and a short 3' end untranslated region (Kato et al., 1990; Takamizawa et al., 1991) . Different isolates of HCV show substantial variability in nucleotide sequence distributed throughout the genome (Okamoto et al., 1991 . Regions encoding the putative envelope glycoproteins, E1 (gp35) and E2 (gp72) are the most variable Hijikata et al., 1991) whereas the 5'UTR is the most conserved Cha et al., 1991 ; Okamoto et al., 1990 : Bukh et al., 1992a .
Many workers investigating sequence variation among HCV isolates have proposed schemes of classification and nomenclatures (Enomoto et al., 1990; Houghton et al., 1991 ; Mori et al., 1992; Okamoto et al., 1992; Cha et al., 1992; Chan et al., 1992; Simmonds et al., 1993a, b) . Recently, a proposal has been made for a unified system of nomenclature . The system proposed by Simmonds is logical because it recognizes that the most divergent isolates of HCV have sequence similarities of less than 72 % (classified as 'types') and within these groupings there may be only 75-86% sequence similarity between clusters of isolates (classified as 'subtypes'; Simmonds et al., 1994) .
It is unknown as to whether sequence variability affects clinical outcome, although there is some evidence that the response of persistently infected patients to treatment with interferon depends to an extent on the genotype of the virus (Kanai et al., 1992; Chemello et al., (Bukh et al., 1992b) . HCV isolates from neighbouring regions, namely Thailand and Nepal 
. primers 5' CACTCTCGAGCACCCTATCAGGCAGT (Garson et al., 1990) and 5' TTCACGCAGAAAGCG-TCTAG . Positive and negative controls were included at the extraction step and in both rounds of amplification. For analysis of the NS5 region, RT-PCR was carried out using primers thought to be highly conserved amongst different isolates of HCV (5' TGGGGATCCCGTATGATACCCGCTGCTTT-GA and 5' GGCGGAATTCCTGGTCATAGCCTCC-GTGAA; Enomoto et al., 1990) and the second round with internal primers described by Chan et al. (1992; 5' CTCAACCGTCACTGAACAGGACAT and 5' CC-ACGACTAGATCATCTCCG) . PCR products were purified by extraction from lowmelting-point agarose and one quarter of the eluate was used in a sequencing reaction with T7 DNA polymerase (Sequenase version 2.0, US Biochemical Corporation) with each internal primer. The template DNA was denatured by boiling for 3 min before annealing the primer and reactions were performed according to the manufacturer's instructions except for the addition of 10 % DMSO. Individual sequences were compared to the EMBL database using the BLAST alignment search program (Karlin & Altschul, 1990; Altschul et al., 1990) . To determine the genotype from sequence data from the 5'UTR, restriction sites for the enzymes HaeIII, RsaI and ScrFI were predicted using Staden-Plus software and interpreted according to the scheme of . Table 1 shows the results of testing 78 serum samples from individuals with a high risk of parenteral exposure to anti-HCV antibodies and HCV RNA. Six cases of post-transfusion hepatitis and three of hepatitis in pregnancy were known to be anti-HCV-positive. Of the remaining 69 samples, 29 proved to be antibody-positive. In 32 antibody-positive cases, sufficient serum remained for RT-PCR analysis (5'UTR). Twenty-four individuals (75 % of anti-HCV-positive cases tested) were positive for HCV RNA in serum.
The nucleotide sequences of PCR products from 24 patients were determined by direct sequencing and are shown in Fig. 1 . In 17 cases, the sequences were identical (HPCMD1) and are 100 % identical to several sequences in the EMBL database including those published for two Indian samples by Bukh et al. (1992b) . Two further sequences were identical (HPCMD2) and are 100% identical to sequences from Taiwan, Peru and Sweden reported by Bukh et al. (1992b) . A further sequence (HPCMD3) was 100% identical to an unpublished sequence in the database (accession number: D29818). The remaining four sequences (HPCMD4-7) were unique; none of them was found to be 100 % identical to sequences in the database.
The subtypes of the seven sequences were determined McOmish et al. (1993) .
by identity with sequences of known subtype and according to the predicted restriction enzyme cleavage pattern Simmonds et al., 1994) . Sequences HPCMD1 to HPCMD4 gave predicted cleavage patterns 'b" using HaeIII-RsaI and 'a' using ScrFI (Fig. 2) . This is consistent with classification as genotype 1 . In these type 1 sequences, the base at nucleotide position -99 is G, consistent with subtype lb rather than la (Stuyver et al., 1993) . This conclusion is supported by the close identity with type lb sequences in the database. The three remaining sequences (HPCMD5 to HPCMD7) gave patterns which cannot be classified using the scheme proposed by McOmish et al. (1993) : HPCMD5-HaeIII-RsaI pattern g, ScrFI pattern a, HPCMD6-HaeIII-RsaI pattern g, ScrFI pattern d and HPCMD7
-ScrFI pattern a but the cleavage predicted for HaeIII-RsaI would yield a novel pattern (Fig. 2) . Sequences HPCMD6 and HPCMD7 closely resemble the sequence HPCENCR (K. Chayama and others, unpublished) which has been classified as type 3b . In order to investigate whether these three isolates might represent novel subtypes of HCV, we sought to determine the sequence of part of the NS5 region.
Analysis of the NS5 region, which shows greater Nucleotide position 1 is equivalent to position 7959 according to Cboo et al. (1991) . ; Eb3 (Chan et al., 1992) ; NE137, NE048, NE274, NE145, NE125 1993a) . We amplified the NS5 region of HCV from the sera which yielded the sequences HPCMD5 to HPCMD7. Fig. 3 shows the sequences of the three PCR products as determined directly on each strand using the internal primers, designated HPCMN5 to HPCMN7, respectively. A pairwise comparison of these three sequences with representatives of genotypes 3a and 3b and provisional genotypes 3c to 3f is shown in Table 2 . The isolates yielding sequences HPCMD6/ HPCMN6 and HPCMD7/HPCMN7 clearly may be classified as subtype 3b with greater than 90 % nucleotide identity in this region of NS5 to established 3b sequences. The isolate yielding sequences HPCMD5/HPCMN5, which was derived from a case of post-transfusion hepatitis, has less than 74 % nucleotide identity to any of the genotype 3 sequences, including from provisional genotypes 3c to 3f. However, a search of the nucleotide database revealed 91% identity to the unpublished sequence of an isolate of HCV from Indonesia (HPCNS5P5). We believe that these two previously unclassified sequences should be considered as a novel subtype within genotype 3 according to the criteria of Simmonds et al. (1994) . Identity to other type 3 sequences in the order of 69-73 % justifies inclusion in the genotype and lack of identity above 75 % to the established and proposed subtypes justifies designation as a novel subtype.
Seventeen isolates of HCV in this study, including all seven renal transplant and both haemodialysis patients who were PCR-positive, had an identical 5'UTR sequence (HPCMD1). We cannot rule out the possibility of a common source for some of these cases. However, sera from seven of nine PCR-positive patients with chronic liver disease also contained virus with this sequence. Analysis of the five viraemic patients with posttransfusion hepatitis produced sequences HPCMD1 5, consistent with this diversity of sequences being present in the blood donor population. Sequences HPCMD6/ HPCMN6 and HPCMD7/HPCMN7 were derived from the other two patients with chronic liver disease.
We conclude that HCV genotype 1 is widespread in this region of southern India along with, and perhaps predominating over, HCV genotype 3. Emerging evidence that infections caused by genotype 1 may be less amenable to treatment with interferon than those caused by genotype 3 (Chemello et al., 1994) , and that there is possibly greater pathogenicity of genotype 1 isolates, bode ill for those infected in this region where healthcare is limited.
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